PTK2 and breast carcinoma: Nguyen et al. demonstrated that GD2+ breast cancer stem cells activate FAK–AKT–ERK–mTOR signaling, with an upregulation of FAK and the downstream proteins Csk, 4E-BP1, and STAT3.